A mutation in the 5'-UTR of GRN gene associated with frontotemporal lobar degeneration: phenotypic variability and possible pathogenetic mechanisms.

Frontotemporal lobar degeneration (FTLD) is a very heterogeneous disorder. It is genetically linked to three major genes: microtubule-associated protein tau (MAPT), progranulin (GRN), and C9ORF72. In particular, mutations in GRN account for 5-10% of all cases and give rise to a wide spectrum of clinical phenotypes, ranging from behavioral frontotemporal dementia (bvFTD) to primary progressive aphasia, including progressive non-fluent aphasia (PNFA) and semantic dementia, and corticobasal syndrome (CBS). We studied a family affected by FTLD whose members showed three different phenotypes: bvFTD, PNFA, and CBS. We performed plasma progranulin measurement before any genetic analyses and, due to the low level detected, we sequenced GRN and found the new mutation EX0-5' splice site A > G in the 5'-UTR region, where no pathogenic mutations had been previously demonstrated. Genetic analyses of MAPT and C9ORF72 were normal. GRN mRNA expression showed about 50% reduction caused by this mutation, and similar results were found for progranulin level. Testing of nonsense mediated RNA decay gave negative results, suggesting a different mechanism of mRNA degradation. In summary, the EX0-5' splice site A > G mutation widens the GRN regions affected by null mutations, including the 5'-UTR, and confirms once more the large phenotypic variability linked to GRN mutations.

[1]  Kevin F. Bieniek,et al.  Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS , 2013, Acta Neuropathologica.

[2]  J. Rohrer,et al.  Phenotypic signatures of genetic frontotemporal dementia. , 2011, Current opinion in neurology.

[3]  J. Shioi,et al.  Extracellular progranulin protects cortical neurons from toxic insults by activating survival signaling , 2011, Neurobiology of Aging.

[4]  L. Agnati,et al.  Optimal Plasma Progranulin Cutoff Value for Predicting Null Progranulin Mutations in Neurodegenerative Diseases: A Multicenter Italian Study , 2011, Neurodegenerative Diseases.

[5]  I. Litvan,et al.  Parkinsonism and Frontotemporal Dementia: The Clinical Overlap , 2011, Journal of Molecular Neuroscience.

[6]  D. Geschwind,et al.  TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers , 2010, Neurology.

[7]  Nick C Fox,et al.  Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  A. Goate,et al.  Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3β , 2010, Protein & Cell.

[9]  A. Goate,et al.  Pathogenic cysteine mutations affect progranulin function and production of mature granulins , 2010, Journal of neurochemistry.

[10]  C. Jack,et al.  Prominent phenotypic variability associated with mutations in Progranulin , 2009, Neurobiology of Aging.

[11]  G. Binetti,et al.  Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide , 2009, Neurobiology of Disease.

[12]  D. Geschwind,et al.  Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative , 2007, The Lancet Neurology.

[13]  J. Hardy,et al.  Heterogeneity within a large kindred with frontotemporal dementia , 2007, Neurology.

[14]  K. Sleegers,et al.  Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia , 2007, Human mutation.

[15]  C. Duijn,et al.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.

[16]  S. Melquist,et al.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.

[17]  G. Ast,et al.  The U1 snRNP Base Pairs with the 5′ Splice Site within a Penta-snRNP Complex , 2003, Molecular and Cellular Biology.

[18]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[19]  G. Schellenberg,et al.  Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.

[20]  S. Zanini,et al.  Variability of the clinical phenotype in an Italian family with dementia associated with an intronic deletion in the GRN gene. , 2011, Journal of Alzheimer's disease : JAD.